CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$ 10,395us-gaap_NetIncomeLoss	$ 9,808us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(2,747)	(1,316)
Depreciation and amortization	1,479	1,463
Write down of other real estate, net of gain on sale		(65)
Amortization of other intangible assets	2,105	1,240
Net amortization of investment securities	1,918	2,191
Share-based compensation	829us-gaap_ShareBasedCompensation	928us-gaap_ShareBasedCompensation
Net gain on sales of residential loans	(1,594)us-gaap_GainLossOnSaleOfLoansAndLeases	(1,239)us-gaap_GainLossOnSaleOfLoansAndLeases
Proceeds from sales of loans held for sale	96,788	84,989
Originations of loans held for sale	(92,717)	(82,627)
Equity in earnings of unconsolidated subsidiaries	(96)	(52)
Increase in cash surrender value of bank-owned life insurance	(968)	(670)
Deferred income taxes	5,339us-gaap_DeferredIncomeTaxExpenseBenefit	5,535us-gaap_DeferredIncomeTaxExpenseBenefit
Net change in other assets and liabilities	(5,020)	(1,169)
Net cash provided by operating activities	15,711	19,016
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	35,942	32,639
Purchases of investment securities available for sale	(95,716)	(18,923)
Proceeds from maturities of and calls on investment securities held to maturity	4,807	3,171
Purchases of investment securities held to maturity	(22,249)
Net loan originations	(36,803)	(66,567)
Proceeds from sales of other real estate	968	771
Purchases of premises and equipment	(1,033)	(416)
Distributions from unconsolidated subsidiaries	214	354
Contributions to unconsolidated subsidiaries		(60)
Proceeds from redemption of FHLB stock	490cpf_ProceedsFromRedemptionOfFHLBStock	601cpf_ProceedsFromRedemptionOfFHLBStock
Net cash used in investing activities	(113,380)	(48,430)
Cash flows from financing activities:
Net increase in deposits	78,342us-gaap_IncreaseDecreaseInDeposits	49,594us-gaap_IncreaseDecreaseInDeposits
Repayments of long-term debt		(4)us-gaap_RepaymentsOfLongTermDebt
Net increase in short-term borrowings	32,000	93,985
Cash dividends paid on common stock	(4,171)us-gaap_PaymentsOfDividendsCommonStock	(3,370)us-gaap_PaymentsOfDividendsCommonStock
Repurchases of common stock and other related costs	(9,288)	(68,873)
Net cash provided by financing activities	96,883	71,332
Net increase (decrease) in cash and cash equivalents	(786)	41,918
Cash and cash equivalents at beginning of period	86,007	49,348
Cash and cash equivalents at end of period	85,221	91,266
Cash paid during the period for:
Interest	1,599us-gaap_InterestPaid	1,654us-gaap_InterestPaid
Income taxes	100us-gaap_IncomeTaxesPaid
Cash received during the period for:
Income taxes		79us-gaap_ProceedsFromIncomeTaxRefunds
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	50	(34)
Net reclassification of loans to other real estate	$ 1,369us-gaap_TransferToOtherRealEstate	$ 372us-gaap_TransferToOtherRealEstate

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.